cUTI

Shares of Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) plunged nearly 80 percent on Wednesday, trading as low as $9.00 per share. The massive selloff is attributed to the company failing to meet the primary endpoint of statistical non-inferiority for IGNITE2 compared to levofloxacin. Here is a...